April 16, 2026

Benitec Biopharma Inc. (BNTC) Stock Analysis: 77.7% Potential Upside Ignites Investor Interest

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is capturing the attention of investors with its innovative approach to genetic medicines. The company, headquartered in..

Compass Therapeutics, Inc. (CMPX) Investor Outlook: Unveiling a 133% Potential Upside in Biotech

For investors looking to capture substantial gains in the healthcare sector, Compass Therapeutics, Inc. (NASDAQ: CMPX) presents a compelling opportunity. With a remarkable potential upside of..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Navigating a 170% Potential Upside with Innovative Biotechnology

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a pioneering company in the biotechnology sector, is attracting attention from investors seeking high-risk, high-reward opportunities. Specializing in the development..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Unpacking a 49.76% Potential Upside

ZoomInfo Technologies Inc. (NASDAQ: GTM), a leading provider of go-to-market intelligence and engagement platforms, presents an intriguing opportunity for investors amid a challenging market environment. With..

Neuronetics, Inc. (STIM) Stock Analysis: Unpacking a 211.75% Potential Upside

For investors seeking opportunities in the healthcare sector, Neuronetics, Inc. (NASDAQ: STIM) presents a compelling case, especially given its significant potential upside. The medical device company,..

Yalla Group Limited (YALA) Stock Analysis: Evaluating a 31.5% Potential Upside in the MENA Social Gaming Sector

Yalla Group Limited (NYSE: YALA), a prominent name in the social networking and gaming sector in the Middle East and North Africa (MENA) region, presents a..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Exploring a 266.50% Potential Upside in the Biotech Sector

Candel Therapeutics, Inc. (NASDAQ: CADL) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within biotechnology. As a clinical-stage biopharmaceutical company, Candel..

Sanara MedTech Inc. (SMTI) Stock Analysis: Unpacking a 79.91% Potential Upside

Sanara MedTech Inc. (NASDAQ: SMTI) stands at the intersection of innovation and opportunity within the healthcare sector, specifically focusing on medical instruments and supplies. With its..

Viant Technology Inc. (DSP) Stock Analysis: Exploring a 50.6% Potential Upside for Investors

Viant Technology Inc. (NASDAQ: DSP) is carving out a prominent position in the Technology sector, specifically within the Software – Application industry, with a market capitalization..

SoundHound AI, Inc. (SOUN) Stock Analysis: Exploring a Potential 86% Upside with Cutting-Edge Voice AI Solutions

SoundHound AI, Inc. (NASDAQ: SOUN), a leading player in the rapidly evolving voice artificial intelligence sector, offers investors a unique opportunity to tap into the burgeoning..

Alumis Inc. (ALMS) Stock Analysis: Biotechnology Breakthrough with 58.94% Upside Potential

Alumis Inc. (ALMS), a pioneering biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating autoimmune disorders. Headquartered in South San..

Nerdy Inc. (NRDY) Stock Analysis: Exploring a Potential 112% Upside in the Online Learning Space

As the digital landscape continues to evolve, the education sector is increasingly embracing technology to enhance learning experiences. Nerdy Inc. (NRDY), a trailblazer in online education,..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 27.93% Potential Upside for Investors

In the ever-evolving realm of healthcare, Cytek Biosciences, Inc. (NASDAQ: CTKB) stands out as a promising player within the medical devices industry. With a market capitalization..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Unlocking 140% Upside Potential in the Biotech Sector

For investors with an eye on emerging biotech opportunities, Tvardi Therapeutics, Inc. (NASDAQ: TVRD) presents a compelling case. With an intriguing 140.15% potential upside based on..

Varex Imaging Corporation (VREX) Investor Outlook: Analyzing a 56% Potential Upside for the Medical Device Maker

Varex Imaging Corporation (NASDAQ: VREX), a prominent player in the healthcare sector, has piqued the interest of investors with its promising outlook and substantial potential upside...

Canopy Growth Corporation (CGC) Investor Outlook: Exploring a 55% Potential Upside

Canopy Growth Corporation (NASDAQ: CGC), a prominent player in the cannabis and hemp industry, is capturing investor attention with its significant potential upside of 55.51%, according..

Erasca, Inc. (ERAS) Stock Analysis: Navigating the Ups and Downs of a $5.66 Billion Biotech Powerhouse

Erasca, Inc. (NASDAQ: ERAS) stands as a notable player in the biotechnology sector, particularly within the burgeoning field of precision oncology. With a strategic focus on..

UroGen Pharma Ltd. (URGN) Stock Analysis: Assessing a 67.88% Potential Upside in the Biotech Sector

UroGen Pharma Ltd. (NASDAQ: URGN) is gaining attention for its significant potential upside in the biotechnology sector, with analysts forecasting a notable 67.88% increase from its..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Exploring a 185.71% Potential Upside in the Medical Devices Sector

Nano-X Imaging Ltd (NASDAQ: NNOX), headquartered in Petah Tikva, Israel, is making waves in the healthcare sector, particularly within the medical devices industry, with its innovative..

Phathom Pharmaceuticals (PHAT) Stock Analysis: A Potential 85% Upside Awaits Investors

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) stands out as a notable player in the biotechnology sector, with a primary focus on developing innovative treatments for gastrointestinal diseases...

Search

Funds

April 16, 2026

Search

Funds

April 16, 2026

FTSE 100

Funds